Pay in 4 interest-free payments of $6.60 Learn more
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2
As of 2026, no peer-reviewed human RCT (Randomised Controlled Trial) has tested subcutaneous GHK-Cu administration [7][9]
The approval comes after a positive recommendation from the European Medicines Agency in May, giving the Danish drugmaker a head start in the race to dominate the emerging weight-loss pill market alongside Eli Lilly's Foundayo, which has yet to clear the EU regulatory pathway
It may also be considered in supportive care conversations related to cataracts, glaucoma, aging, alcoholism, heart disease, liver disease, lung disease, Alzheimer's disease, Parkinson's disease, osteoarthritis, immune system concerns, and other chronic wellness concerns
The score is calculated from the data of the nutrition facts table and the composition data (fruits, vegetables and legumes)
